Stay updated on Dociparstat Sodium with Standard Induction in AML Clinical Trial

Sign up to get notified when there's something new on the Dociparstat Sodium with Standard Induction in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dociparstat Sodium with Standard Induction in AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing multiple states (v3.3.3). The previous per-state location blocks were removed (v3.3.2).
    Difference
    2%
    Check dated 2025-12-25T18:44:46.000Z thumbnail image
  4. Check
    30 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2; no study details or functionality were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T18:14:43.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 with minor UI/functional updates that do not alter the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:49:26.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Removed the site-wide funding/operating status banner from the page; this change does not affect trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:53:40.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Screenshots indicate only minor UI/layout adjustments with no changes to core trial details (title, condition, eligibility, arms, or primary outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:17:40.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Core content updated with new entity (Jazz Pharmaceuticals) and removal of an existing one (Chimerix); version bumped to v3.2.0, and a government funding/operating-status notice added.
    Difference
    3%
    Check dated 2025-10-05T10:09:54.000Z thumbnail image

Stay in the know with updates to Dociparstat Sodium with Standard Induction in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dociparstat Sodium with Standard Induction in AML Clinical Trial page.